We are live on
!
Find out more
SGL
Sonic GP LLC Portfolio holdings
AUM
$45.4M
1-Year Est. Return
5.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
+5.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
+$18.9M
(+14%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
8.69%
Top 10 Holdings %
Top 10 Hldgs %
76.09%
Holding
26
New
1
Increased
2
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manchester United
MANU
|
+$15.5M |
| 2 |
Regenxbio
RGNX
|
+$10.6M |
| 3 |
SiriusPoint
SPNT
|
+$914K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Foods
USFD
|
+$7.39M |
| 2 |
Radian Group
RDN
|
+$6.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.61% |
| 2 | Financials | 16.37% |
| 3 | Industrials | 15.32% |
| 4 | Materials | 12.21% |
| 5 | Communication Services | 12.2% |
Similar funds
MC
OAM
CIA
AIM
VCM
VFA
CGI
SFM
Sonic GP LLC's Q2 2023 Portfolio in Review
As of Q2 2023, Sonic GP LLC held 26 positions worth $150M, up 14% from $131M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Sonic GP LLC deployed $13M of net new capital in Q2 2023, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Manchester United: 750,000 shares worth $18.3M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the most notable exit was US Foods, an estimated $7.39M sold.
- Sonic GP LLC's largest Q2 2023 buy was Manchester United: 750,000 shares worth $18.3M.
- Sonic GP LLC added most to Regenxbio in Q2 2023, an estimated $10.6M increase.
- Sonic GP LLC fully exited US Foods in Q2 2023, selling an estimated $7.39M.
- Sonic GP LLC's ten largest holdings make up 76% of its $150M portfolio in Q2 2023.
- Sonic GP LLC opened 1 new position and closed 2 in Q2 2023.
- Sonic GP LLC's portfolio value rose 14% quarter-over-quarter to $150M.
Based on Sonic GP LLC's 13F filing for Q2 2023, filed 14 Aug 2023.